I
119THCONGRESS
1
STSESSION H. R. 2075
To prohibit the Federal Government from conducting or supporting any
research involving human fetal tissue that is obtained pursuant to an
induced abortion, and to prohibit the solicitation or knowing acquisition,
receipt, or acceptance of a donation of such tissue.
IN THE HOUSE OF REPRESENTATIVES
MARCH11, 2025
Mr. O
NDER(for himself, Mr. SMITHof New Jersey, Mr. LATTA, Mr. KELLY
of Mississippi, Mrs. M
ILLERof Illinois, Mr. HARRISof Maryland, Mr.
G
REENof Tennessee, Mr. LAMALFA, Mr. GROTHMAN, Mr. CLOUD, Mr.
S
ELF, Mr. WEBERof Texas, Mr. STAUBER, Mr. ELLZEY, Mr. EZELL,
Mr. G
UEST, Mr. BURCHETT, Mr. CRANE, Mr. FALLON, Mrs. BIGGSof
South Carolina, Mr. P
ALMER, Mr. BIGGSof Arizona, Ms. GREENEof
Georgia, and Mr. F
LEISCHMANN) introduced the following bill; which was
referred to the Committee on Energy and Commerce
A BILL
To prohibit the Federal Government from conducting or sup-
porting any research involving human fetal tissue that
is obtained pursuant to an induced abortion, and to
prohibit the solicitation or knowing acquisition, receipt,
or acceptance of a donation of such tissue.
Be it enacted by the Senate and House of Representa-1
tives of the United States of America in Congress assembled, 2
VerDate Sep 11 2014 20:50 Mar 25, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H2075.IH H2075
ssavage on LAPJG3WLY3PROD with BILLS 2
•HR 2075 IH
SECTION 1. SHORT TITLE. 1
This Act may be cited as the ‘‘Protecting Life and 2
Integrity in Research Act of 2025’’. 3
SEC. 2. NO RESEARCH INVOLVING HUMAN FETAL TISSUE 4
OBTAINED PURSUANT TO AN INDUCED ABOR-5
TION. 6
(a) I
NGENERAL.— 7
(1) I
N GENERAL.—No Federal department, 8
agency, or office may conduct, fund, approve, or oth-9
erwise support any research involving human fetal 10
tissue that is obtained pursuant to an induced abor-11
tion. 12
(2) D
EVELOPMENT OF NEW , ETHICAL CELL 13
LINES.—Subsection (a) does not limit the authority 14
of any Federal department, agency, or office to de-15
velop or support the development of new, high-effi-16
ciency cell lines, including for the production of vac-17
cines and genetic vectors, so long as the cell lines 18
are not derived from human fetal tissue that is ob-19
tained pursuant to an induced abortion. 20
(3) R
ESEARCH INVOLVING HUMAN FETAL TIS -21
SUE OBTAINED AFTER A MISCARRIAGE OR STILL -22
BIRTH PERMITTED.—Any research of any Federal 23
department, agency, or office on human fetal tissue 24
obtained after a miscarriage or stillbirth shall be 25
conducted or supported in accordance with section 26
VerDate Sep 11 2014 20:50 Mar 25, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H2075.IH H2075
ssavage on LAPJG3WLY3PROD with BILLS 3
•HR 2075 IH
498A of the Public Health Service Act (42 U.S.C. 1
289g–1). 2
(b) A
MENDMENTS TO THE PHSA LIMITINGHUMAN 3
F
ETALTISSUERESEARCH TOTISSUEOBTAINEDAFTER 4
AMISCARRIAGE ORSTILLBIRTH.—Section 498A of the 5
Public Health Service Act (42 U.S.C. 289g–1) is amend-6
ed— 7
(1) in the section heading, by striking ‘‘
TRANS-8
PLANTATION OF FETAL TISSUE ’’ and inserting 9
‘‘
HUMAN FETAL TISSUE OBTAINED AFTER A 10
MISCARRIAGE OR STILLBIRTH ’’; 11
(2) by amending subsection (a) to read as fol-12
lows: 13
‘‘(a) E
STABLISHMENT OF PROGRAM.—The Secretary 14
may conduct or support research on human fetal tissue 15
obtained after a miscarriage or a stillbirth.’’; 16
(3) in subsection (b)— 17
(A) in paragraph (1)(B), by inserting ‘‘if 18
the human fetal tissue is intended for trans-19
plantation,’’ before ‘‘the donation’’; and 20
(B) in paragraph (2)— 21
(i) by striking subparagraph (A); and 22
(ii) by redesignating subparagraphs 23
(B) and (C) as (A) and (B), respectively; 24
VerDate Sep 11 2014 20:50 Mar 25, 2025 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H2075.IH H2075
ssavage on LAPJG3WLY3PROD with BILLS 4
•HR 2075 IH
(4) in subsection (c)(1)(B), by striking ‘‘pursu-1
ant to a spontaneous or induced abortion or pursu-2
ant to’’ and inserting ‘‘after a miscarriage or’’; and 3
(5) by amending subsection (g) to read as fol-4
lows: 5
‘‘(g) D
EFINITIONS.—In this section: 6
‘‘(1) H
UMAN FETAL TISSUE .—The term 7
‘human fetal tissue’ means tissue or cells obtained 8
from a dead unborn child pursuant to an induced 9
abortion, a miscarriage, or a stillbirth. 10
‘‘(2) M
ISCARRIAGE.—The term ‘miscarriage’ 11
means the involuntary death of an unborn child who 12
was carried in the womb for a period of less than 13
20 weeks. 14
‘‘(3) S
TILLBIRTH.—The term ‘stillbirth’ means 15
the involuntary death of an unborn child who was 16
carried in the womb for a period of 20 weeks or 17
more. 18
‘‘(4) U
NBORN CHILD.—The term ‘unborn child’ 19
has the meaning given such term in section 1841(d) 20
of title 18, United States Code.’’. 21
(c) C
ONFORMINGREPEAL.—Section 113 of the Na-22
tional Institutes of Health Revitalization Act of 1993 (42 23
U.S.C. 289g–1 note) is repealed. 24
VerDate Sep 11 2014 20:50 Mar 25, 2025 Jkt 059200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\H2075.IH H2075
ssavage on LAPJG3WLY3PROD with BILLS 5
•HR 2075 IH
SEC. 3. PROHIBITION AGAINST SOLICITATION OR KNOWING 1
ACQUISITION, RECEIPT, OR ACCEPTANCE OF 2
A DONATION OF HUMAN FETAL TISSUE 3
KNOWING THAT THE TISSUE WAS OBTAINED 4
PURSUANT TO AN INDUCED ABORTION. 5
(a) I
NGENERAL.—Section 498B(c)(1) of the Public 6
Health Service Act (42 U.S.C. 289g–2(c)(1)) is amended 7
to read as follows: 8
‘‘(1) solicit or knowingly acquire, receive, or ac-9
cept a donation (excluding any transfer for purposes 10
of autopsy or burial) of human fetal tissue knowing 11
that— 12
‘‘(A) a human pregnancy was deliberately 13
initiated to provide such tissue; or 14
‘‘(B) the tissue was obtained pursuant to 15
an induced abortion; or’’. 16
(b) C
ONFORMINGCHANGES.—Section 498B of the 17
Public Health Service Act (42 U.S.C. 289g–2), as amend-18
ed by subsection (a), is further amended— 19
(1) by striking subsection (b); 20
(2) by redesignating subsections (c) through (e) 21
as subsections (b) through (d), respectively; and 22
(3) in subsection (c), as redesignated— 23
(A) in paragraph (1), by striking ‘‘(a), (b), 24
or (c)’’ and inserting ‘‘(a) or (b)’’; and 25
VerDate Sep 11 2014 20:50 Mar 25, 2025 Jkt 059200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 E:\BILLS\H2075.IH H2075
ssavage on LAPJG3WLY3PROD with BILLS 6
•HR 2075 IH
(B) in paragraph (2), by striking ‘‘or 1
(b)(3)’’. 2
Æ
VerDate Sep 11 2014 20:50 Mar 25, 2025 Jkt 059200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6301 E:\BILLS\H2075.IH H2075
ssavage on LAPJG3WLY3PROD with BILLS